Literature DB >> 27787714

Ocular Pharmacokinetics.

Chandrasekar Durairaj1.   

Abstract

Although the fundamental concepts of pharmacokinetics remain the same, ocular pharmacokinetics has its own challenges due to the uniqueness of barrier properties posed by various ocular tissues and its growing complexity with different routes of ocular administration. A thorough understanding of the barrier nature will aid in tailoring a drug or its carrier's physicochemical properties to its advantage. In order to deliver the right payload of a drug at the target site, various approaches can be taken to leverage the pharmacokinetics that includes molecular design based on desirable physicochemical properties, formulation approaches, and alternative routes of administration. In this chapter, a brief overview of the barrier properties with respect to various routes of administration is presented along with the physicochemical properties that influence the pharmacokinetics of ocular drugs. Recent advances in ocular pharmacokinetics are discussed in addition to new perspectives in interpreting existing data.

Keywords:  Anterior segment; Disposition; Intracameral; Intravitreal; Pharmacokinetics; Posterior segment; Topical

Mesh:

Year:  2017        PMID: 27787714     DOI: 10.1007/164_2016_32

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  6 in total

Review 1.  Challenges and opportunities for drug delivery to the posterior of the eye.

Authors:  Fernando J Cabrera; Daniel C Wang; Kartik Reddy; Ghanashyam Acharya; Crystal S Shin
Journal:  Drug Discov Today       Date:  2019-06-05       Impact factor: 7.851

2.  Bioequivalence Study Methods with Pharmacokinetic Endpoints for Topical Ophthalmic Corticosteroid Suspensions and Effects of Subject Demographics.

Authors:  Yoriko Harigaya; Xiaojian Jiang; Hongling Zhang; Parthapratim Chandaroy; Ethan M Stier; Yuzhuo Pan
Journal:  Pharm Res       Date:  2018-11-15       Impact factor: 4.200

Review 3.  Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy.

Authors:  Tirth J Shah; Mandi D Conway; Gholam A Peyman
Journal:  Clin Ophthalmol       Date:  2018-11-01

4.  Retinal and Corneal Toxicity and Pharmacokinetic Analysis of Intraocular Injection of Ganciclovir in Rabbit Eyes.

Authors:  Bin-Jia Sun; Rong-Mei Peng; Qing Lu; Jing Hong
Journal:  J Ophthalmol       Date:  2019-05-07       Impact factor: 1.909

5.  Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts.

Authors:  Thaksaporn Thongseesuksai; Phanthipha Wongwai; Thidarut Boonmars; Oranuch Sanpool; Porntip Laummaunwai
Journal:  Int Ophthalmol       Date:  2019-10-05       Impact factor: 2.031

6.  Efficacy of systemic administration of riboflavin on a rabbit model of corneal alkali burn.

Authors:  Maksym Żuk; Ekaterina Lobashova; Olga Żuk; Sławomir Wierzba
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.